Hexavalent Vaccine
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) (NCT05289271) | Merck Sharp & Dohme LLC | 2022-03-25 |
Track Hexavalent Vaccine automatically
Every clearance here is in the API, with alerts when new ones post.